21 Sept 2020

Antibody engineered to prevent clotting in stroke and heart attack

A/Prof Christoph Hagemeyer and Dr Erik Westein explain
the research to stop pathological blood clotting. See video

Monash researchers have invented an antibody which can prevent the formation of bad clots, such as those in stroke and heart attack.

Heart attack and stroke remain the leading causes of mortality and morbidity worldwide. Current anti-thrombotic (anti-clotting) therapies can, and do, cause severe bleeding complications because they also interfere with normal blood clotting. Four out of five patients who receive antiplatelet therapy still have recurring cardiovascular events.

15-21 Sept 2020 Central Clinical School publications

Dr Erik Westein and A/Prof Christoph
Hagemeyer explain their research on 
blood clotting prevention. See video
Recent publications featuring research as notified by PubMed during 15-21 Sep 2020 from Central Clinical School affiliated researchers in the following departments. The below is not a comprehensive list:
  • Anaesthesiology and Perioperative Medicine
  • Australian Centre for Blood Diseases
  • Diabetes
  • Gastroenterology
  • Infectious Diseases
  • Medicine - Alfred
  • MSHC
  • Neuroscience
  • Psychiatry
Related Posts Plugin for WordPress, Blogger...